Intensity Therapeutics jumps after Nasdaq grants compliance extension
ReutersDec 5, 2025 12:40 PM
Shares of drugmaker Intensity Therapeutics INTS.O rise 8.6% to 50 cents premarket
Co gets 180-day extension from the Nasdaq exchange to meet the minimum $1 share price requirement
Deadline set for June 1, 2026; shares must stay above $1 for 10 consecutive days, says co
Co continues late-stage trials of INT230-6 for soft tissue sarcoma and breast cancer
INT230-6 is injected into tumors to kill cancer cells and trigger immune response - INTS
Up to last close, stock down ~74% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
TradingKey 2025 Markets Recap & Outlook | Global Central Banks 2026 amid Post‑Easing Recovery and Diverging Paths
TradingKey - In 2025, major global central banks will largely maintain an accommodative stance, but the policy pace will decelerate notably. As the easing cycle draws to a close, how will global monetary policy evolve?TradingKey
10 hours ago
TradingKey 2025 Markets Recap & Outlook | Wall Street Bullish on 2026: S&P 500 Forecast at 8,000 with AI Gains and Cyclical Stocks Soaring
TradingKey - As 2025 draws to a close, the U.S. stock market has delivered a series of exciting and astonishing moments. As 2026 approaches, major Wall Street banks remain confident about the outlook for U.S. equities, with an average forecast for the S&P 500 index reaching 7,500 points.TradingKey
Wed, Dec 24
Ripple Price Prediction: Why Is XRP Price Falling? Can It Rise to $10 in the Future?
XRP has weakened this year due to profit-taking, capital outflows, and its correlation with Bitcoin. Despite support from potential spot ETFs and positive regulatory developments, significant market divergence, liquidity uncertainty, and macroeconomic uncertainty remain high. XRP's price is likely tTradingKey
Wed, Dec 24
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital baTradingKey
Fri, Dec 19
Tradingkey
